EFFECTIVE osteoporosis
treatment reduces the risk of
premature death due to fracture,
illness and injury by 10% in older,
frailer people at high risk of
fracture, according to research
discussed at a ‘Beating Brittle
Bones’ seminar co-hosted yesterday
in Sydney by the Garvan Institute of
Medical Research and the National
Council for Women of Australia.
The mortality reduction wasn’t
related to age, with Professor John
Eisman of the Garvan Institute
saying it’s not exactly clear how
deaths are prevented with effective
osteoporosis treatment.
“We believe it may be because
certain medications not only
strengthen bones to reduce
fractures, but also improve a
person’s ability to cope and recover
from illness and injury by
preventing frailty,” he said.The above article was sent to subscribers in Pharmacy Daily's issue from 27 May 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 May 10
THE Pharmacy Guild of Australia has formally expressed its concerns regarding the potential merger between Sigma and Chemist Warehouse (PD 07 Dec 2023) to the Australian Competition and Consumer Commission (ACCC).
FROM 01 May, pharmacists will be able to dispense Verzenio (abemaciclib) through the PBS to treat Australian patients with an invasive form of early breast cancer that is at high risk of recurring after initial treatment.
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.